Coreg CR Once-Daily Sustains Blood Pressure Reduction Over 24 Hours–Study
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
GlaxoSmithKline's Coreg CR once-daily version of beta blocker carvedilol offers a sustained reduction in both diastolic and systolic blood pressure over a 24-hour period, the company said March 14